Haemophilus influenzae disease - Annual Epidemiological Report for 2023
In 2023, 5 234 confirmed cases of invasive Haemophilus influenzae disease were reported in the EU/EEA, representing a continued increase compared to the previous year (3 983 in 2022) and a substantial rise from pandemic-era figures (1 693 in 2021, 1 838 in 2020), coinciding with the post-COVID-19 return to typical respiratory disease transmission patterns.
- The notification rate rose to 1.2 cases per 100 000 population, the highest observed in the past five years, up from 0.9 in 2022 and 0.4 in both 2020 and 2021.
- Age-specific rates remained highest among infants under one year of age (6.41 per 100 000 population), followed by those aged 65 years and older (3.2 per 100 000 population).
- Serotyping data were available for 60% of cases. Among cases with known serotype, non-capsulated strains continued to dominate, accounting for 81% of infections. Serotype f was the most frequent capsulated strain, responsible for 6% (194 cases) of all cases, followed by serotype b 5% (164 cases)
- In 2023, serotype b (Hib) represented 5% of known serotyped cases, reflecting a slight decline from 9.1% in 2022. The low proportion of serotype b (Hib) reported continues to reflect the strong effect of the Hib vaccination programmes in EU/EEA countries.
Haemophilus influenzae disease - Annual Epidemiological Report for 2023
English (873.69 KB - PDF)All annual epidemiological reports on Haemophilus influenzae disease
This external quality assessment (EQA) was organised within the IBDLabNet framework on behalf of the ECDC to assess current EU/EEA laboratory capacity for the detection and characterisation of H. influenzae in both non-culture and culture-based settings.
External quality assessment scheme for identification, antimicrobial susceptibility testing and molecular typing of Haemophilus influenzae, 2026
English (1.64 MB - PDF)
For 2024, 30 EU/EEA countries reported 37 605 cases of hepatitis B virus (HBV) infection, corresponding to a crude rate of 7.5 cases per 100 000 population.
Hepatitis B - Annual Epidemiological Report for 2024
English (717.41 KB - PDF)
In 2024, 28 540 cases of hepatitis C were reported in 29 EU/EEA countries, corresponding to a crude rate of 7.1 cases per 100 000 population.
Hepatitis C - Annual Epidemiological Report for 2024
English (858.45 KB - PDF)
In 2024, 73 tetanus cases were reported in the EU/EEA 15 of which (21%) were confirmed cases.
Tetanus - Annual Epidemiological Report 2024
English (1001.72 KB - PDF)
In 2023, 12 EU Member States and one EEA country reported 6 254 SSIs from a total of 421 397 surgical procedures for nine types of surgical procedures.
Healthcare-associated infections: surgical site infections - Annual Epidemiological Report for 2023
English (1.31 MB - PDF)
Share this page